Efficacy and safety of fulranumab as monotherapy in patients with moderate to severe, chronic knee pain of primary osteoarthritis: a randomised, placebo- and active-controlled trial
Author:
Affiliation:
1. Janssen Research & Development, LLC; Titusville NJ USA
2. Janssen Research & Development, LLC; Fremont CA USA
Funder
Janssen Research and Development
Publisher
Hindawi Limited
Subject
General Medicine
Reference29 articles.
1. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines;Arthritis Rheum,2000
2. OARSI recommendations for the management of hip and knee osteoarthritis;Zhang;Osteoarthritis Cartilage,2010
3. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials;Bjordal;BMJ,2004
4. Opioids for chronic pain: new evidence, new strategies, safe prescribing;Leon-Casasola;Am J Med,2013
5. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study;Johnsen;Arch Intern Med,2005
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A comprehensive review of phase 2/3 trials in osteoarthritis: an expert opinion;Expert Opinion on Emerging Drugs;2024-08-05
2. Monoclonal antibodies as analgesia of chronic low back pain: a systematic review and meta-analysis of efficacy and safety;Annals of Clinical and Experimental Neurology;2024-07-08
3. Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials;BMJ Open;2024-01
4. miR-101 Promotes Degradation of Cartilage Matrix in Osteoarthritis;Journal of Biomaterials and Tissue Engineering;2022-11-01
5. Comparative benefits and harms of individual opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised trials;British Journal of Anaesthesia;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3